Sentiment Trading

Acurx Pharmaceuticals is facing market challenges, including a significant stock price decline, but continues to pursue its mission of developing innovative antibiotics to combat bacterial infections.

Acurx Pharmaceuticals is scheduled to release its Q1 2025 earnings on May 13, 2025, with investors eagerly awaiting the report to gain insights into the company’s financial health and stock performance.